Vijaya Shankar Nataraj

Employment

• Aurigene Discovery Technologies Ltd Group Leader
  2017 - Present
• Novozymes Sout Scientist-I
  2015 - 2017
• University of Surrey PDRA
  2015 - 2015
• Aurigene Discovery Technologies Ltd Senior Research Scientist
  2008 - 2011
• Enzene Biosciences Pvt Ltd Scientist
  2007 - 2008
• AstraZeneca India Private Limited Research Associate
  2005 - 2007

Education

• Bangalore University Masters
  2003 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Structural and binding studies of cyclin‐dependent kinase 2 with NU6140 inhibitor
  Chemical Biology & Drug Design 2021 DOI: 10.1111/cbdd.13941
  +Save
• Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313
  Acta Crystallographica Section F Structural Biology Communications 2020 DOI: 10.1107/s2053230x20009243
  +Save
• Ternary complex formation of AFN‐1252 with Acinetobacter baumannii FabI and NADH: Crystallographic and biochemical studies
  Chemical Biology & Drug Design 2020 DOI: 10.1111/cbdd.13686
  +Save
• The role of hydrophobicity in tuberculosis evolution and pathogenicity
  Scientific Reports 2017 DOI: 10.1038/s41598-017-01501-0
  +Save
• THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
  Nature Microbiology 2016 DOI: 10.1038/nmicrobiol.2015.6
  +Save
• Mycolic acids: deciphering and targeting the A chilles' heel of the tubercle bacillus
  Molecular Microbiology 2015 DOI: 10.1111/mmi.13101
  +Save
• Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
  Tuberculosis - Expanding Knowledge 2015 DOI: 10.5772/59585
  +Save
• Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis
  Tuberculosis 2015 DOI: 10.1016/j.tube.2015.02.009
  +Save
• MKAN27435 Is Required for the Biosynthesis of Higher Subclasses of Lipooligosaccharides in Mycobacterium kansasii
  PLOS ONE 2015 DOI: 10.1371/journal.pone.0122804
  +Save
• Biochemical and Structural Characterization of Mycobacterial Aspartyl-tRNA Synthetase AspS, a Promising TB Drug Target
  PLoS ONE 2014 DOI: 10.1371/journal.pone.0113568
  +Save